scholarly journals Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus

2015 ◽  
Vol 6 (3) ◽  
pp. 101 ◽  
Author(s):  
Wisit Cheungpasitporn ◽  
Narat Srivali ◽  
Charat Thongprayoon ◽  
Patompong Ungprasert
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Acute Pancreatitis ◽  
Type 2 Diabetes Mellitus ◽  
Side Effect ◽  
The Novel ◽  
Novel Therapy ◽  
Rare Side Effect

Acute Pancreatitis in Patients With a Medical History of Type 2 Diabetes Mellitus

Pancreas ◽  
2020 ◽  
Vol 49 (4) ◽  
pp. 591-597
Author(s):  
Bo Xiao ◽  
Hai-bo Xu ◽  
Zhi-qiong Jiang ◽  
Jin-xiang Hu ◽  
Guo-dong Yang
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Acute Pancreatitis ◽  
Type 2 Diabetes Mellitus ◽  
Medical History ◽  
History Of

DPP-4 inhibitors and hypoglycemia in the patients with type 2 diabetes mellitus

2013 ◽  
Vol 59 (5) ◽  
pp. 72-80
Author(s):  
Iu Sh Khalimov
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Adverse Events ◽  
Clinical Condition ◽  
Hypoglycemic Agents ◽  
The Novel ◽  
Oral Hypoglycemic Agents ◽  
Novel Approaches

The incidence of hypoglycemia remains rather high among the population of patients with type 2 diabetes mellitus (DM2) especially in those treated with the traditional oral hypoglycemic agents. Hypoglycemia is one of the most frequent adverse events encountered by a physician dealing with diabetic (DM2) patients. At the same time, the novel approaches are currently available that allow this clinical condition to be avoided.

Sign in / Sign up

Export Citation Format

Share Document